| MeSH term | MeSH ID | Detail |
|---|---|---|
| Leukemia, Myeloid | D007951 | 52 associated lipids |
| Biliary Fistula | D001658 | 13 associated lipids |
Total
2
Zaragozic acid A
Zaragozic acid A is a lipid of Polyketides (PK) class. Zaragozic acid a is associated with abnormalities such as Hypercholesterolemia, Diabetes Mellitus, Non-Insulin-Dependent, Cardiovascular morbidity, Atherosclerosis and Infection. The involved functions are known as Anabolism, Sterol Biosynthesis Pathway, isoprenoid biosynthetic process, Biochemical Pathway and Adverse effects. Zaragozic acid a often locates in Endoplasmic reticulum, membrane, viral nucleocapsid location, Cell surface, Hepatic and Membrane. The associated genes with Zaragozic acid A are DPM1 gene, PMM2 gene, STN gene, SLC6A7 gene and Amyloid beta-Protein Precursor. The related lipids are Sterols, Fatty Acids, Membrane Lipids, farnesoic acid and Unilamellar Vesicles. The related experimental models are Mouse Model.
Cross Reference
Introduction
To understand associated biological information of Zaragozic acid A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Zaragozic acid A?
Zaragozic acid A is suspected in Hypercholesterolemia, Cardiovascular Diseases, Prion Diseases, Coronary Artery Disease, Diabetes Mellitus, Non-Insulin-Dependent, Cardiovascular morbidity and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Zaragozic acid A
PubChem Associated disorders and diseases
What pathways are associated with Zaragozic acid A
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Zaragozic acid A through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Zaragozic acid A?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Zaragozic acid A?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Zaragozic acid A?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Zaragozic acid A?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Zaragozic acid A?
Mouse Model
Mouse Model are used in the study 'Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid.' (Haeuptle MA et al., 2011).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Zaragozic acid A
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chen TS et al. | The preparation of zaragozic acid A analogues by directed biosynthesis. | 1994 | J. Antibiot. | pmid:8002393 |
| Hasumi K et al. | Competitive inhibition of squalene synthetase by squalestatin 1. | 1993 | J. Antibiot. | pmid:8501015 |
| Onishi JC et al. | Antimicrobial activity of viridiofungins. | 1997 | J. Antibiot. | pmid:9186560 |
| Baxter A et al. | Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. | 1992 | J. Biol. Chem. | pmid:1601846 |
| Correll CC and Edwards PA | Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro. | 1994 | J. Biol. Chem. | pmid:8276863 |
| Gibbs JB et al. | Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. | 1993 | J. Biol. Chem. | pmid:8463291 |
| Lindsey S and Harwood HJ | Inhibition of mammalian squalene synthetase activity by zaragozic acid A is a result of competitive inhibition followed by mechanism-based irreversible inactivation. | 1995 | J. Biol. Chem. | pmid:7721822 |
| Bostedor RG et al. | Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol. | 1997 | J. Biol. Chem. | pmid:9083051 |
| Ravid T et al. | The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase. | 2000 | J. Biol. Chem. | pmid:10964918 |
| Bate C et al. | Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. | 2004 | J. Biol. Chem. | pmid:14754889 |
| Haeuptle MA et al. | Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid. | 2011 | J. Biol. Chem. | pmid:21183681 |
| Vukelic S et al. | Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. | 2010 | J. Biol. Chem. | pmid:19903814 |
| Brusselmans K et al. | Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. | 2007 | J. Biol. Chem. | pmid:17483544 |
| Liu CI et al. | Binding modes of zaragozic acid A to human squalene synthase and staphylococcal dehydrosqualene synthase. | 2012 | J. Biol. Chem. | pmid:22474324 |
| Kahlon AK et al. | Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus. | 2010 | J. Biomol. Struct. Dyn. | pmid:20645653 |
| Pastar I et al. | Skin Metabolite, Farnesyl Pyrophosphate, Regulates Epidermal Response to Inflammation, Oxidative Stress, and Migration. | 2016 | J. Cell. Physiol. | pmid:26916741 |
| Linetti A et al. | Cholesterol reduction impairs exocytosis of synaptic vesicles. | 2010 | J. Cell. Sci. | pmid:20103534 |
| Zúñiga-Hertz JP et al. | Distinct pathways of cholesterol biosynthesis impact on insulin secretion. | 2015 | J. Endocrinol. | pmid:25453115 |
| Stein W et al. | Prevention of transplant coronary artery disease by prenylation inhibitors. | 2011 | J. Heart Lung Transplant. | pmid:21458297 |
| Molina S et al. | The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. | 2007 | J. Hepatol. | pmid:17156886 |
| Doerner KC et al. | Regulation of cholesterol 7 alpha-hydroxylase expression by sterols in primary rat hepatocyte cultures. | 1995 | J. Lipid Res. | pmid:7665995 |
| Petras SF et al. | HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells. | 1999 | J. Lipid Res. | pmid:9869647 |
| Quade-Lyssy P et al. | Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. | 2013 | J. Lipid Res. | pmid:23966666 |
| Procopiou PA et al. | The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues. | 1994 | J. Med. Chem. | pmid:7932554 |
| Biftu T et al. | Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition. | 1994 | J. Med. Chem. | pmid:8308869 |
| Bamford MJ et al. | The squalestatins: synthesis and biological activity of some C3-modified analogues; replacement of a carboxylic acid or methyl ester with an isoelectronic heterocyclic functionality. | 1995 | J. Med. Chem. | pmid:7658437 |
| Procopiou PA et al. | The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues. | 1996 | J. Med. Chem. | pmid:8691471 |
| Ponpipom MM et al. | Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives. | 1994 | J. Med. Chem. | pmid:7966163 |
| Pedretti A et al. | Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking. | 2002 | J. Med. Chem. | pmid:11906287 |
| Chan C et al. | The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors. | 1996 | J. Med. Chem. | pmid:8568810 |
| Dufresne C et al. | Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase. | 1993 | J. Nat. Prod. | pmid:8289063 |
| Michikawa M and Yanagisawa K | Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death. | 1999 | J. Neurochem. | pmid:10349836 |
| Crick DC et al. | Selective inhibition of cholesterol biosynthesis in brain cells by squalestatin 1. | 1995 | J. Neurochem. | pmid:7643114 |
| Fünfschilling U et al. | Critical time window of neuronal cholesterol synthesis during neurite outgrowth. | 2012 | J. Neurosci. | pmid:22649242 |
| Naito S et al. | Novel approach to the zaragozic acids. Enantioselective total synthesis of 6,7-dideoxysqualestatin H5. | 2002 | J. Org. Chem. | pmid:12054955 |
| Freeman-Cook KD and Halcomb RL | A symmetry-based formal synthesis of zaragozic acid A. | 2000 | J. Org. Chem. | pmid:10987953 |
| Rondini EA et al. | Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes. | 2015 | J. Pharmacol. Exp. Ther. | pmid:26427720 |
| Rondini EA et al. | Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat Hepatocytes. | 2016 | J. Pharmacol. Exp. Ther. | pmid:27225895 |
| Stankewich MC et al. | Alterations in cell cholesterol content modulate Ca(2+)-induced tight junction assembly by MDCK cells. | 1996 | Lipids | pmid:8869884 |
| Michikawa M and Yanagisawa K | Apolipoprotein E4 isoform-specific actions on neuronal cells in culture. | 1999 | Mech. Ageing Dev. | pmid:10360679 |
| Cannell RJ et al. | Follow-up of natural products isolation. | 2012 | Methods Mol. Biol. | pmid:22367909 |
| Gardner RG et al. | In vivo action of the HRD ubiquitin ligase complex: mechanisms of endoplasmic reticulum quality control and sterol regulation. | 2001 | Mol. Cell. Biol. | pmid:11390656 |
| Kocarek TA et al. | Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver. | 1998 | Mol. Pharmacol. | pmid:9730906 |
| Kocarek TA and Mercer-Haines NA | Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. | 2002 | Mol. Pharmacol. | pmid:12391282 |
| Forsman U et al. | 4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures. | 2010 | Nat. Chem. Biol. | pmid:20526342 |
| Lasserre R et al. | Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. | 2008 | Nat. Chem. Biol. | pmid:18641634 |
| Kelly MJ and Roberts SM | Synthetic chemistry. Combating cholesterol. | 1995 | Nature | pmid:7816124 |
| Calter MA and Zhu C | Scope and diastereoselectivity of the "interrupted" Feist-Bénary reaction. | 2002 | Org. Lett. | pmid:11796051 |
| Calter MA et al. | Rapid synthesis of the 7-deoxy zaragozic acid core. | 2002 | Org. Lett. | pmid:11796052 |
| Liu N et al. | Identification and Heterologous Production of a Benzoyl-Primed Tricarboxylic Acid Polyketide Intermediate from the Zaragozic Acid A Biosynthetic Pathway. | 2017 | Org. Lett. | pmid:28605916 |